1. Home
  2. CLS vs TECH Comparison

CLS vs TECH Comparison

Compare CLS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLS
  • TECH
  • Stock Information
  • Founded
  • CLS 1994
  • TECH 1976
  • Country
  • CLS Canada
  • TECH United States
  • Employees
  • CLS N/A
  • TECH N/A
  • Industry
  • CLS Electrical Products
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLS Technology
  • TECH Health Care
  • Exchange
  • CLS Nasdaq
  • TECH Nasdaq
  • Market Cap
  • CLS 9.7B
  • TECH 7.8B
  • IPO Year
  • CLS 1998
  • TECH 1989
  • Fundamental
  • Price
  • CLS $194.74
  • TECH $54.89
  • Analyst Decision
  • CLS Strong Buy
  • TECH Buy
  • Analyst Count
  • CLS 10
  • TECH 12
  • Target Price
  • CLS $178.20
  • TECH $70.00
  • AVG Volume (30 Days)
  • CLS 4.2M
  • TECH 2.1M
  • Earning Date
  • CLS 07-28-2025
  • TECH 08-06-2025
  • Dividend Yield
  • CLS N/A
  • TECH 0.58%
  • EPS Growth
  • CLS 55.91
  • TECH N/A
  • EPS
  • CLS 4.59
  • TECH 0.83
  • Revenue
  • CLS $10,587,200,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • CLS N/A
  • TECH $7.07
  • Revenue Next Year
  • CLS $13.73
  • TECH $5.72
  • P/E Ratio
  • CLS $42.44
  • TECH $66.02
  • Revenue Growth
  • CLS 20.52
  • TECH 4.72
  • 52 Week Low
  • CLS $40.25
  • TECH $46.01
  • 52 Week High
  • CLS $214.47
  • TECH $83.33
  • Technical
  • Relative Strength Index (RSI)
  • CLS 71.30
  • TECH 52.65
  • Support Level
  • CLS $153.11
  • TECH $49.71
  • Resistance Level
  • CLS $214.47
  • TECH $60.06
  • Average True Range (ATR)
  • CLS 9.91
  • TECH 2.12
  • MACD
  • CLS 2.71
  • TECH 0.05
  • Stochastic Oscillator
  • CLS 67.85
  • TECH 50.05

About CLS Celestica Inc.

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: